论文部分内容阅读
目的 :评价还原性谷胱苷肽滴眼液对角膜上皮病的治疗价值。方法 :选择无明确致病原因 (如眼睑位置异常、急性眼部感染及严重干眼症 )的点、片状角膜上皮缺损患者 85例 ,随即分为谷胱苷肽治疗组 (5 5例 )及素高捷疗对照组 (30例 ) ,疗程 2周 ,定期随诊 ,以量化标准记录患者用药后主要症状及客观临床检查结果。结果 :治疗 7天及 14天 ,实验组总有效率分别是 6 7.3%及 83.6 % ;对照组总有效率分别是 33.3%及 5 0 .0 % ,两组总有效率经 x2检验有显著学差异。结论 :谷胱苷肽滴眼液可作为一种角膜营养剂 ,促进角膜上皮的损伤修复。
Objective: To evaluate the therapeutic value of reducing glutathione eye drops on corneal epithelial disease. Methods: A total of 85 patients with corneal epithelial defect were randomly divided into glutathione group (55 cases), non-etiologic group (85 cases) And control group (30 cases). The course of treatment was 2 weeks. Regular follow-up was carried out to record the main symptoms and objective clinical examination results of patients after treatment. Results: The total effective rates in the experimental group were respectively 7.33% and 83.6% at 7 days and 14 days after treatment. The total effective rates in the control group were 33.3% and 50.0%, respectively. The total effective rate in the two groups was significant difference. Conclusion: Glutathione eyedrops can be used as a corneal nutrient to promote corneal epithelial injury repair.